<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">Lymphoproliferative disease</z:e> of granular T lymphocyte (T-LDGL), also known as T-cell large granular lymphocyte <z:hpo ids='HP_0001909'>leukemia</z:hpo>, is a clonal disorder of cytotoxic T lymphocytes that is clinically manifested as <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Association with <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> is common </plain></SENT>
<SENT sid="2" pm="."><plain>In 9 patients, T-LDGL is reported as presenting as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical characteristics were similar to acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Morphologic evidence of increased granular lymphocytes in the peripheral blood and an excess of CD3(+)/CD8(+)/CD57(+) cells in the bone marrow were found in most cases </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> was ineffective, but noncytotoxic <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> generally produced a good response </plain></SENT>
<SENT sid="6" pm="."><plain>After a median follow-up of 49 months, 5 patients had died from the disease or related complications </plain></SENT>
<SENT sid="7" pm="."><plain>Median survival was 40 months </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> can be a presenting manifestation of T-LDGL, and T-LDGL should be considered in the differential diagnosis of acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>